小儿麻醉新进展.pdf

东南大学学报(医学版)
2006,Jan;25(1):73O75
()
JSoutheastUnivMedSciEdi·73·

matrixmetalloproteinase22activityinratmesangialcellsvia
[5]VUTH,WERBZ.Matrixmetalloproteinases:effectorsofde2
transforminggrowthfactor2beta[J].ExpNephrol,2001,9:249O257.
velopmentandnormalphysiology[J].GenesDev,2000,14:
[13]McLENNANSV,MARTELLSKY,YUEDK.Highglucose
2123O2133.
concentrationinhibitstheexpressionofmembranetypemetal2
[6]BODEW,FERNANDEZOCATALANC,GRAMSF,etal.In2
loproteinasebymesangialcells:possibleroleinmesangium
sightsintoMMPOTIMPinteractions[J].AnnNYAcadSci,
accumulation[J].Diabetologia,2000,43:642O648.
1999,878:73O91.
[14]LUPIAE,ELLIOTSJ,LENZO,etal.IGFO1decreasescolla2
[7]WUK,SETTYS,MAUERSM,etal.Alteredkidneymatrix
gendegradationindiabeticNODmesangialcells:implications
geneexpressioninearlystagesofexperimentaldiabetes[J].
fordiabeticnephropathy[J].Diabetes,1999,48:1638O1644.
ActaAnatBasel,1997,158:155O165.
[15]McLENNANSV,MARTELLSKY,YUEDK.Effectsof
[8]EBIHARALJ,NAKAMURAT,SHIMADAN,etal.Increased
mesangiumglycationonmatrixmetalloproteinaseactivities:
plasmametalloproteinase9concentrationsprecededevelopment
possibleroleindiabeticnephropathy[J].Diabetes,2002,51:
ofmicroalbuminuriainnoninsulindependentdiabetesmellitus
2612O2618.
[J].AmJKidenyDis,1998,32:544O550.
[16]于晓燕,李才,何泽,等.糖基化终末产物对大鼠肾皮质基
[9]TASHIROK,KOYANAGII,OHARAI,etal.Levelsofurinary
质金属蛋白酶2活性和表达的影响[J].中华内分泌代谢
matrixmetalloproteinase29(MMPO9)andrenalinjuriesinpa2
杂志,2003,19:402O405.
tientswithtype2diabeticnephropathy[J].JClinLabAnal,
[17]BARICOSWH,CORTEZSL,DEBOISBLANCM,etal.Trans2
2004,18(3):206O210.
forminggrowthfactor2betaisapotentinhibitorofextracellular
[10]GIUSEPPED,MARIAAA,DIEGOG,etal.MatrixMetallo2
matrixdegradationculturedhumanmesangialcells[J].JAm
proteinase2maybeamarkerofmicroangiopathyinchildren
SocNephrol,1999,10:795.
andadolescentswithtype1diabetes[J].DiabetesCare,
[18]McLENNANSV,WANGXY,MORENOV,etal.Connec2
2004,27:273O274.
tivetissuegrowthfactormediateshighglucoseeffectsonma2
[11]McLENNANSV,KELLYDJ,COXAJ,etal.Decreasedma2
t